Endoxifen is a new potent inhibitor of PKC: A potential therapeutic agent for bipolar disorder

Endoxifen is a new potent inhibitor of PKC: A potential therapeutic agent for bipolar disorder Design and synthesis of triarylacrylonitrile analogues of tamoxifen with improved binding selectivity to protein kinase C Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization Synthesis of anilino-monoindolylmaleimides as potent and selective PKCβ inhibitors Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism Rationally Designed Analogs of Tamoxifen with Improved Calmodulin Antagonism Design and Synthesis of Norendoxifen Analogues with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities